Peptidomimetic-based antibody surrogate for HER2

• Κύριοι συγγραφείς: Mengmeng Zheng (Συγγραφέας), Chunpu Li (Συγγραφέας), Mi Zhou (Συγγραφέας), Ru Jia (Συγγραφέας), Fengyu She (Συγγραφέας), Lulu Wei (Συγγραφέας), Feng Cheng (Συγγραφέας), Qi Li (Συγγραφέας), Jianfeng Cai (Συγγραφέας), Yan Wang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2021-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Inhibition of human epidermal growth factor receptor 2 mediated cell signaling pathway is an important therapeutic strategy for HER2-positive cancers. Although monoclonal antibodies are currently used as marketed drugs, their large molecular weight, high cost of production and susceptibility to prot...